Abstract
Background The activated coagulation time (ACT) is a rapid measurement of a patient’s level of heparin anticoagulation during cardiac catheterization. Patients receiving warfarin therapy occasionally are seen at the catheterization laboratory for emergent procedures. The effects of warfarin on ACT activity have not been previously described. We compared the ACT and the international normalized ratios (INR) in 77 patients receiving warfarin and 57 patients who were not receiving any anticoagulation (controls). Results Both the mean ACT (131 ± 17.0 seconds) and INR (2.5 ± 0.90 seconds) of the anticoagulated patients differed from the controls (ACT = 115 ± 14.5 seconds, INR = 1.0 ± 0.10 seconds; P < 0.05). The ACT increased linearly with INR in the warfarin group ( r = 0.70, P < .001). There was no relation between ACT and INR in the control group. Conclusion Patients receiving warfarin therapy will have a linear increase in ACT develop similar to patients receiving heparin therapy. (Am Heart J 1998;136:477-9.)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
